Business | Theatre of blood

The trial of Elizabeth Holmes gets under way

The former boss of a notorious failed health-care startup could face jail

A CROWD OF reporters, drawn by the drama and glamour of the event, jostled outside a courtroom in San Jose on August 31st to witness the opening of what may be the next, perilous, act for a woman once touted as the next Steve Jobs and the world’s youngest self-made female billionaire. Jury selection was beginning for the fraud trial of Elizabeth Holmes, the former boss of Theranos, a startup which attempted to revolutionise the process of blood testing but failed spectacularly in 2016 after the press and regulators probed the company’s inflated claims.

This article appeared in the Business section of the print edition under the headline “Theatre of blood”

The threat from the illiberal left

From the September 4th 2021 edition

Discover stories from this section and more in the list of contents

Explore the edition

Discover more

Food packaging with "Notpla Coating" is pictured at Notpla.

Could seaweed replace plastic packaging?

Companies are experimenting with new ways to reduce plastic waste

A sequoiq tree with a metal detector scanning around the Silicon valley and California.

Has Sequoia Capital outgrown its business model?

Venture capital’s hardiest perennial gets back to its roots


A man cutting the red tape that tiies him.

On stupid rules and quick wins

Why every boss can benefit from asking employees what most infuriates them


TikTok wants Western consumers to shop like the Chinese

It still has some convincing to do

Will the trouble ever end for Volkswagen and its rivals?

From strikes to Trump tariffs, calamities abound

After Northvolt’s failure, who will make Europe’s EV batteries?

The continent looks ever more reliant on Asian producers